Join Now

Category Archives: BioUtah News

CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

By Natalie Themm | Published June 29, 2023

Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks of patient follow-up

| Tagged | Comments Off on CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

By Natalie Themm | Published June 29, 2023

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

| Tagged | Comments Off on Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

By Natalie Themm | Published June 29, 2023

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

| Tagged | Comments Off on Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

By Natalie Themm | Published June 15, 2023

UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting Ewing sarcoma

| Tagged | Comments Off on CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

By Natalie Themm | Published June 15, 2023

On June 13, the U.S. Food and Drug Administration (FDA) issued the final guidance: Content of Premarket Submissions for Device Software Functions. The final guidance provides information regarding the recommended documentation sponsors should include in premarket submissions for the FDA’s evaluation of the safety and effectiveness of device software functions. The guidance replaces the FDA’s […]

Also posted in Federal News | | Comments Off on FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

Denali Therapeutics, Alucent Biomedical, Present to Utah Life Sciences Innovation Caucus

By Denise Bell | Published June 15, 2023

Utah legislators on Wednesday, June 14, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol. BioUtah President and CEO, Kelvyn Cullimore, kicked off the meeting and introduced representatives from Denali Therapeutics and Alucent Biomedical who presented before the ULSIC. Cindy Dunkle, chief people officer for Denali, described the company’s […]

Also posted in Policy News | | Comments Off on Denali Therapeutics, Alucent Biomedical, Present to Utah Life Sciences Innovation Caucus

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

By Natalie Themm | Published June 14, 2023

Recursion’s small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating neurovascular disease with approximately 360,000 symptomatic patients in the United States and EU5.

| Tagged | Comments Off on Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

By Natalie Themm | Published June 14, 2023

Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and response

| Tagged | Comments Off on Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.

By admin | Published June 8, 2023

Acquisitions broaden Merit’s therapeutic platform with diverse dialysis product solutions and expand its access catheter offering Acquisitions projected to add approximately $30 million of revenue, on an annualized basis, in key strategic markets that leverage existing commercial footprint Merit re-affirms full-year 2023 financial guidance on stand-alone basis and updates full-year 2023 financial guidance to include […]

| Comments Off on Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.

KOLOSIS BIO AND MTF BIOLOGICS FORGE STRATEGIC PARTNERSHIP TO ENTER SURGICAL INCISION MARKET

By admin | Published June 1, 2023

SALT LAKE CITY, Utah – May 30, 2023 (OrthoSpineNews)- Kolosis BIO (Kolosis), a leading provider of biologics solutions, and MTF Biologics, a global tissue processor and nonprofit organization, are excited to announce their partnership in the surgical incision market. This strategic collaboration represents Kolosis BIO’s expansion into a new area of healthcare, while providing MTF […]

| Comments Off on KOLOSIS BIO AND MTF BIOLOGICS FORGE STRATEGIC PARTNERSHIP TO ENTER SURGICAL INCISION MARKET

Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue

By admin | Published May 31, 2023

Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Member Zhenya Lindgardt as Interim President and CEO Engages Leading Strategy House to Evaluate Best Pathways Toward Targeting Enhanced Revenue Generation at Significantly Reduced Operating Costs Nadia Altomare Expected to Move from Chief Commercial Officer to Consulting Role to […]

| Comments Off on Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue

Altitude Lab Relocates to Gateway’s BioHive Hub

By admin | Published May 25, 2023

Altitude’s new facility will be housed within Recursion’s expanded headquarters and will promote increased collaboration in Downtown Salt Lake City’s rapidly growing biotech innovation ecosystem.SALT LAKE CITY, May 25, 2023 (GLOBE NEWSWIRE) — Altitude Lab announced today that its incubator program and facility will leave Research Park to grow its operation in the Gateway’s BioHive […]

| Comments Off on Altitude Lab Relocates to Gateway’s BioHive Hub

A Special Thanks To Our Legacy and Platinum Elite Members